- Home
- BETR vs ORMP Comparison
BETR vs ORMP Comparison
Compare BETR & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BETR | ORMP |
|---|---|---|
| Founded | 2014 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 229.1M | 197.6M |
| IPO Year | 2021 | 2010 |
Fundamental Metrics
Financial Performance| Metric | BETR | ORMP |
|---|---|---|
| Price | $10.95 | $4.49 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $25.71 | N/A |
| AVG Volume (30 Days) | ★ 413.4K | 136.9K |
| Earning Date | 11-12-2026 | 11-12-2026 |
| Dividend Yield | N/A | ★ 5.35% |
| EPS Growth | 20.88 | ★ 412.50 |
| EPS | N/A | ★ 2.76 |
| Revenue | ★ $164,872,000.00 | $2,000,000.00 |
| Revenue This Year | $24.97 | N/A |
| Revenue Next Year | $33.91 | N/A |
| P/E Ratio | ★ N/A | $1.70 |
| Revenue Growth | ★ 51.97 | 49.25 |
| 52 Week Low | $9.81 | $2.09 |
| 52 Week High | $92.69 | $5.47 |
Technical Indicators
Market Signals| Indicator | BETR | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 39.68 | 45.98 |
| Support Level | N/A | $4.54 |
| Resistance Level | $13.20 | $5.01 |
| Average True Range (ATR) | 0.77 | 0.13 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 38.05 | 30.56 |
Price Performance
Historical ComparisonAbout BETR Better Home & Finance Holding Company
Better Home & Finance Holding Co is a technology-enabled homeownership company that provides mortgage, home equity, and related services through a digital platform. The company operates through two reportable segments: Home Finance, which focuses on residential mortgage origination, including purchase, refinance, and home equity products, generating revenue mainly from loan sales; and Banking, which, through its U.K. subsidiary Birmingham Bank, offers a range of financial products and services to consumers and small businesses. It generates the majority of its revenue from the Home Finance segment.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.